Literature DB >> 19255708

Accelerated clinical decline in well-educated patients with frontotemporal lobar degenerations.

Robert Perneczky1, Corina Pohl, Susanne Bornschein, Hans Förstl, Alexander Kurz, Janine Diehl-Schmid.   

Abstract

Education seems to protect against symptoms of neurodegeneration, but highly educated individuals experience faster cognitive decline after the onset of dementia. No studies on the effects of education on the clinical course in frontotemporal lobar degenerations (FTLD) exist. The aim of the study was to explore the effect of education on the rate of clinical deterioration in patients with FTLD. Thirty-five patients with FTLD were recruited and followed up for 20 months in average. A correlation was calculated between years of education and monthly rate of change on the clinical dementia rating scale sum of the boxes (CDR-SOB). A linear regression analysis with the CDR-SOB monthly rate of change as dependent, and the educational years and other variables possibly associated with the rate of clinical decline as independent variables was performed. There was a significant positive association between education and CDR-SOB monthly rate of change, indicating a faster decline in the well-educated. Education was the only significant predictor of clinical deterioration.

Entities:  

Mesh:

Year:  2009        PMID: 19255708     DOI: 10.1007/s00406-009-0004-6

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  40 in total

1.  Non-fluent progressive aphasia: cerebral metabolic patterns and brain reserve.

Authors:  Robert Perneczky; Janine Diehl-Schmid; Corina Pohl; Alexander Drzezga; Alexander Kurz
Journal:  Brain Res       Date:  2006-12-20       Impact factor: 3.252

2.  Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia.

Authors:  Mario F Mendez; Jill S Shapira; Aaron McMurtray; Eliot Licht
Journal:  Am J Geriatr Psychiatry       Date:  2007-01       Impact factor: 4.105

3.  Behavioral disturbances in the course of frontotemporal dementia.

Authors:  J Diehl-Schmid; C Pohl; R Perneczky; H Förstl; A Kurz
Journal:  Dement Geriatr Cogn Disord       Date:  2006-09-04       Impact factor: 2.959

Review 4.  Brain reserve and cognitive decline: a non-parametric systematic review.

Authors:  Michael J Valenzuela; Perminder Sachdev
Journal:  Psychol Med       Date:  2006-05-02       Impact factor: 7.723

5.  The Bayer Activities of Daily Living Scale (B-ADL).

Authors:  I Hindmarch; H Lehfeld; P de Jongh; H Erzigkeit
Journal:  Dement Geriatr Cogn Disord       Date:  1998       Impact factor: 2.959

6.  Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial.

Authors:  J B Deakin; S Rahman; P J Nestor; J R Hodges; B J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2003-12-10       Impact factor: 4.530

7.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

8.  Establishing short-term prognosis in Frontotemporal Lobar Degeneration spectrum: role of genetic background and clinical phenotype.

Authors:  Barbara Borroni; Mario Grassi; Chiara Agosti; Enrico Premi; Silvana Archetti; Antonella Alberici; Giuseppe Bellelli; Luigi Caimi; Monica Di Luca; Alessandro Padovani
Journal:  Neurobiol Aging       Date:  2010-02       Impact factor: 4.673

9.  Measuring progression in frontotemporal dementia: implications for therapeutic interventions.

Authors:  C M Kipps; P J Nestor; C E Dawson; J Mitchell; J R Hodges
Journal:  Neurology       Date:  2008-05-27       Impact factor: 9.910

10.  Memantine for behavioral disturbances in frontotemporal dementia: a case series.

Authors:  Margaret M Swanberg
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Apr-Jun       Impact factor: 2.703

View more
  7 in total

1.  Education mediates microstructural changes in bilateral hippocampus.

Authors:  Fabrizio Piras; Andrea Cherubini; Carlo Caltagirone; Gianfranco Spalletta
Journal:  Hum Brain Mapp       Date:  2011-02       Impact factor: 5.038

2.  SORL1 genetic variants and cerebrospinal fluid biomarkers of Alzheimer’s disease.

Authors:  Liang-Hao Guo; Christine Westerteicher; Xin-Hui Wang; Martina Kratzer; Amalia Tsolakidou; Meizi Jiang; Timo Grimmer; Simon M Laws; Panagiotis Alexopoulos; Hideaki Bujo; Alexander Kurz; Robert Perneczky
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09       Impact factor: 5.270

Review 3.  Molecular imaging in cognitive impairment: the relevance of cognitive reserve, importance of multisite longitudinal trials and challenges of standardised analysis.

Authors:  Giovanni Lucignani; Robert Perneczky
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02       Impact factor: 9.236

4.  Predicting functional decline in behavioural variant frontotemporal dementia.

Authors:  Keith A Josephs; Jennifer L Whitwell; Stephen D Weigand; Matthew L Senjem; Bradley F Boeve; David S Knopman; Glenn E Smith; Robert J Ivnik; Clifford R Jack; Ronald C Petersen
Journal:  Brain       Date:  2011-01-20       Impact factor: 13.501

5.  A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration.

Authors:  Stefan Poljansky; Bernd Ibach; Barbara Hirschberger; Peter Männer; Hans Klünemann; Göran Hajak; Jörg Marienhagen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-01-05       Impact factor: 5.270

Review 6.  [Cognitive reserve and its relevance for the prevention and diagnosis of dementia].

Authors:  R Perneczky; P Alexopoulos; G Schmid; C Sorg; H Förstl; J Diehl-Schmid; A Kurz
Journal:  Nervenarzt       Date:  2011-03       Impact factor: 1.214

7.  Impairments in Episodic-Autobiographical Memory and Emotional and Social Information Processing in CADASIL during Mid-Adulthood.

Authors:  Angelica Staniloiu; Friedrich G Woermann; Hans J Markowitsch
Journal:  Front Behav Neurosci       Date:  2014-06-25       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.